May 22, 2017

CEO of Huntsman Cancer Institute Inducted Alongside President Obama to American Philosophical Society

SALT LAKE CITY – Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah, has been elected to highly distinguished membership in the American Philosophical Society (APS), joining a group of 32 inductees that includes former United States president Barack Obama.

Apr 12, 2017

Huntsman Cancer Institute Investigators Elected to American Academy of Arts and Sciences

University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.

Apr 11, 2017

Huntsman Cancer Institute Researchers Share Expertise at National Cancer Meeting

More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics.

Mar 30, 2017

HCI CEO and Director Testifies before Congress on the Value of Federally-Funded Medical Research

Mary Beckerle, PhD, testified before the United States House of Representatives Committee on Oversight and Government Reform on the impact of federally-funded cancer research.

Feb 24, 2017

HCI Researcher Receives Merit Award for Prostate Cancer Research

Huntsman Cancer Institute researcher Andrew Hahn, MD, received the Conquer Cancer Foundation of ASCO Merit Award. The award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.

Jan 25, 2017

Huntsman Cancer Institute Scientists Identify Bone Degradation Process Within Metastatic Breast Cancer

Once breast cancer spreads through the body, it can degrade a patient’s healthy bones, causing numerous problems. Scientists at Huntsman Cancer Institute (HCI) at the University of Utah have identified a new way that bones get destroyed through cancer. And they’ve also learned how to block that destruction with a new drug. Initial tests with patients show promising results.

Jan 12, 2017

Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease

Jan 10, 2017

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).